A. Mingorance

Nogo-A Expression in the Human Hippocampus in Normal Aging and in Alzheimer Disease

I. Ferrer, J. D. del Río, E. Soriano, 2006, Journal of neuropathology and experimental neurology.

PrP(106–126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH‐oxidase independently of PrPc

A. Aguzzi, J. D. del Río, E. Soriano, 2005, FEBS letters.

Regeneration of lesioned entorhino‐hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo‐66/NgR signaling

E. Soriano, M. Nieto‐Sampedro, J. Río, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Overexpression of myelin-associated glycoprotein after axotomy of the perforant pathway

E. Soriano, J. A. Rı́o, A. Mingorance, 2005, Molecular and Cellular Neuroscience.

Genetic epilepsies and COVID‐19 pandemic: Lessons from the caregiver perspective

R. Toledano, A. Gil-Nagel, I. García-Morales, 2020, Epilepsia.

Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions

M. Schwab, E. Soriano, B. Tang, 2004, Molecular and Cellular Neuroscience.

Diagnostic gap in genetic epilepsies: A matter of age

R. Toledano, A. Gil-Nagel, I. García-Morales, 2020, Epilepsy & Behavior.

[Analysis of the family impact and needs of Dravet's syndrome in Spain].

A. Mingorance, Á. Aledo-Serrano, 2020 .

Semaphorin 6C leads to GSK-3-dependent growth cone collapse and redistributes after entorhino-hippocampal axotomy

E. Soriano, F. Burgaya, J. A. Rı́o, 2006, Molecular and Cellular Neuroscience.

Nogo, myelin and axonal regeneration

J. A. Rı́o, A. Mingorance, Eduardo Soriano García, 2004 .